Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP - Protein kinase A pathway

Molecular and Cellular Endocrinology

Volumn 348, Issue 1, 2012, Pages 47-54

  Caruso, Carla ^a   Carniglia, Lila ^a   Durand, Daniela ^a   Gonzalez, Patricia V ^b   Scimonelli, Teresa N ^b   Lasaga, Mercedes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Astrocytes; BDNF; CAMP; CREB; MC4R; PKA

Indexed keywords

ADENYLATE CYCLASE; ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; BACTERIUM LIPOPOLYSACCHARIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ALPHA-MSH; ANIMALS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; NF-KAPPA B; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION;

EID: 80755187744     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.036     Document Type: Article

References (57)

1. Ao Y., Park H.Y., Olaizola-Horn S., Gilchrest B.A. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation. Exp. Cell Res. 1998, 244:117-124.
2. Avni D., Ernst O., Philosoph A., Zor T. Role of CREB in modulation of TNF-α and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol. Immunol 2010, 47:1396-1403.
3. Béjot Y., Prigent-Tessier A., Cachia C., Giroud M., Mossiat C., Bertrand N., Garnier P., Marie C. Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem. Int. 2011, 58:102-111.
4. Bertolini A., Tacchi R., Vergoni A.V. Brain effects of melanocortins. Pharmacol. Res. 2009, 59:13-47.
5. Binder E., Scharfman H. Brain-derived neurotrophic factor. Growth Factors 2004, 22:123-131.
6. Breit A., Büch T.R., Boekhoff I., Solinski H.J., Damm E., Gudermann T. Alternative G protein coupling and biased agonism: new insights into melanocortin-4 receptor signalling. Mol. Cell. Endocrinol. 2011, 331:232-240.
7. Buzas B., Rosenberger J., Kim K.W., Cox B.M. Inflammatory mediators increase the expression of nociciptin/orphanin FQ in rat astrocytes in culture. Glia 2002, 39:237-246.
8. Caruso C., Mohn C., Karara A.L., Rettori V., Watanobe H., Schiöth H.B., Seilicovich A., Lasaga M. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 2004, 79:278-286.
9. Caruso C., Durand D., Schiöth H.B., Rey R., Seilicovich A., Lasaga M. Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 2007, 148:4918-4926.
10. Caruso C., Sánchez M., Durand D., Pérez M.C., Lasaga M., Scimonelli T. α-Melanocyte-stimulating hormone modulates lipopolysaccharide plus interferon-γ-induced tumor necrosis factor-α expression but not tumor necrosis factor-α receptor expression in cultured hypothalamic neurons. J. Neuroimmunol. 2010, 227:52-59.
11. Catania A., Lonati C., Sordi A., Carlin A., Leonardi P., Gatti S. The melanocortin system in control of inflammation. ScientificWorld J. 2010, 10:1840-1853.
12. Chai B., Li J.Y., Zhang W., Newman E., Ammori J., Mulholland M.W. Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase. Peptides 2006, 27:2846-2857.
13. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fisher J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., Van der Ploeg L.H. Activation of melanocortin type 3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26:97-102.
14. Climent E., Sancho-Tello M., Miñana R., Barettino D., Guerri C. Astrocytes in culture express the full-length Trk-B receptor and respond to brain derived neurotrophic factor by changing intracellular calcium levels: effect of ethanol exposure in rats. Neurosci. Lett. 2000, 288:53-56.
15. Crosio C., Valle C., Casciati A., Iaccarino C., Carri M.T. Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis. PLOS one 2011, 6:e1787.
16. Czyzyk T.A., Sikorski M.A., Yang L., McKnight S. Disruption of the RII β subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice. P.N.A.S. 2008, 105:276-281.
17. De Santi L., Polimeni G., Cuzzocrea S., Esposito E., Sessa E., Annunziata P., Bramanti P. Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment. Curr. Med. Chem. 2011, 18:1775-1784.
18. Dmitrieva V.G., Povarova O.V., Skvortsova V.I., Limborska S.A., Myasoedov N.F., Dergunova L.V. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell. Mol. Neurobiol. 2010, 30:71-79.
19. Giuliani D., Mioni C., Altavilla D., Leone S., Bazzani C., Minutoli L., Bitto A., Cainazzo M., Marini H., Zaffe D., Botticelli A., Pizzala R., Savio M., Necchi D., Schiöth H.B., Bertolini A., Squadrito F., Guarini S. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 2006, 147:1126-1135.
20. Gonzalez P.V., Schiöth H.B., Lasaga M., Scimonelli T. Memory impairment induced by IL-1beta is reversed by alpha-MSH through central melanocortin-4 receptors. Brain Behav. Immun. 2009, 6:817-822.
21. Haskell-Luevano C., Monck E.K. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortins-4 receptor. Regul. Pept. 2001, 99:1-7.
22. Haus-Seuffert P., Meisterernst M. Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol. Cell. Biochem. 2000, 212:5-9.
23. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
24. Ichiyama T., Zhao H., Catania A., Furukawa S., Lipton J.M. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp. Neurol. 1999, 157:359-365.
25. Jiang Y., Jiang Y., Wei N., Lu T., Zhu J., Xu G., Liu X. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 2011, 172:398-405.
26. Juric D.M., Loncar D., Carman-Krzan M. Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha1- and beta1/beta2-adrenergic receptors. Neurochem. Int. 2008, 52:297-306.
27. Kairisalo M., Korhonen L., Sepp M., Pruunsild P., Kukkonen J.P., Kivinen J., Timmusk T., Blomgren K., Lindholm D. NF-kappaB-dependent regulation of brain-derived neurotrophic factor in hippocampal neurons by X-linked inhibitor of apoptosis protein. Eur. J. Neurosci. 2009, 30:958-966.
28. Kiprianova I., Freiman T.M., Desiderato S., Schwab S., Galmbacher R., Gillardon F., Spranger M. Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat. J. Neurosci. Res 1999, 56:21-27.
29. Lasaga M., Debeljuk L., Durand D., Scimonelli T.N., Caruso C. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides 2008, 29:1825-1835.
30. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
32. Lonze B.E., Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002, 35:605-623.
33. Manna S.K., Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 1998, 161:2873-2880.
34. Mayr B.M., Canettieri G., Montminy M.R. Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc. Natl. Acad. Sci. USA 2001, 98:10936-10941.
35. McTigue D.M., Horner P.J., Stokes B.T., Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 1998, 18:5354-5365.
36. Mountjoy K., Mortrud M., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 1994, 8:1298-1308.
37. Nicholson J.R., Peter J.C., Lecourt A.C., Barde Y.A., Hofbauer K.G. Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J. Neuroendocrinol. 2007, 19:974-982.
38. Okonogi K., Gettys T.W., Uhing R.J., Tarry W.C., Adams D.O., Prpic V. Inhibition of prostaglandin E2-stimulated cAMP accumulation by lipopolysaccharide in murine peritoneal macrophages. J. Biol. Chem. 1991, 266:10305-10312.
39. Risoe P.K., Wang Y., Stuestol J.F., Aasen A.O., Wang J.E., Dahle M.K. Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo. Biochim. Biophys. Acta 2007, 1772:32-39.
40. Rodrigues A.R., Pignatelli D., Almeida H., Gouveia A.M. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signalling mechanism. Mol. Cell. Endocrinol. 2009, 303:74-81.
41. Roy S., Pinard S., Chouinard L., Gallo-Payet N. Adrenocorticotropin hormone (ACTH) effects on MAPK phosphorylation in human fasciculata cells and in embryonic kidney 293 cells expressing human melanocortin 2 receptor (MC2R) and MC2R accessory protein (MRAP) β. Mol. Cell. Endocrinol. 2011, 336:31-40.
42. Sarkar A., Sreenivasan Y., Manna S.K. Alpha-melanocyte stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages. FEBS Lett. 2003, 553:286-294.
43. Sarkar S., Légradi G., Lechan R.M. Intracerebroventricular of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH- neurons of the hypothalamic paraventricular nucleus. Brain Res. 2002, 945:50-59.
44. Sato Y., Chen Y., Kato T., Tanaka Y., Tozuka Y., Mase M., Ageyama N., Ono F., Terao K., Yoshikawa Y., Hisatsune T. White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci. Res. 2009, 65:71-78.
45. Selkirk J.V., Nottebaum L.M., Lee J., Yang W., Foster A.C., Lechner S.M. Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 2007, 52:459-466.
46. Shadrina M.I., Dolotov O.V., Grivennikov I.A., Slominsky P.A., Andreeva L.A., Inozemtseva L.S., Limborska S.A., Myasoedov N.F. Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Neurosci. Lett. 2001, 308:115-118.
47. Sinha P., Schiöth H.B., Tatro J. Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered alpha-MSH. Brain Res. 2004, 1001:150-158.
48. Spencer J.D., Schallreuter K.U. Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling. Endocrinology 2009, 150:1250-1258.
49. Sutton G.M., Duos B., Patterson L.M., Berthoud H.-R. Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signalling in rat solitary nucleus. Endocrinology 2005, 146:3739-3747.
50. Tao X., Finkbeiner S., Arnold D.B., Shaywitz A.J., Greenberg M.E. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726.
51. Tao Y.X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 2010, 31:506-543.
52. Vongs A., Lynn N.M., Rosenblum C.I. Activation of MAP kinase by MC4-R through PI3 kinase. Regul. Pept. 2004, 120:113-118.
53. Xu B., Goulding E.H., Zang K., Cepoi D., Cone R.D., Jones K.R., Tecott L.H., Reichardt L.F. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 2003, 6:736-742.
54. Yoon S.W., Goh S.H., Chun J.S., Cho E.W., Lee M.K., Kim K.L., Kim J.J., Kim C.J., Poo H. Alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J. Biol. Chem. 2003, 278:32914-32920.
55. Yoon H., Oh Y.T., Lee J.Y., Choi J.H., Lee J.H., Baik H.H., Kim S.S., Choe W., Yoon K.S., Ha J., Kang I. Activation of AMP-activated protein kinase by kainic acid mediates brain-derived neurotrophic factor expression through a NF-kappaB dependent mechanism in C6 glioma cells. Biochem. Biophys. Res. Commun. 2008, 371:495-500.
56. Zhang B., Liu S., Perpetua M.D., Walker W.H., Harbrecht B.G. Cytokines increase CRE binding but decrease CRE-mediated reporter activity in rat hepatocytes by increasing c-Jun. Hepatology 2004, 39:1343-1352.
57. Zhang Y., Wu X., He Y., Kastin A.J., Hsuchou H., Rosenblum C.I., Pan W. Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway. J Neurochem. 2009, 110:390-399.